(Q36268383)

13 August 2017

1 reference

title

Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options (English)

1 reference

hospital-acquired infection

13 August 2017

main subject

Pseudomonas aeruginosa

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

1 reference

Marilee D Obritsch

1

1 reference

13 August 2017

Douglas N Fish

series ordinal

2

1 reference

13 August 2017

Robert MacLaren

series ordinal

3

1 reference

13 August 2017

Rose Jung

series ordinal

4

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

25

1 reference

13 August 2017

issue

10

1 reference

13 August 2017

page(s)

1353-1364

1 reference

Ventilator-associated pneumonia due to Pseudomonas aeruginosa

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Pseudo-outbreak of multiresistant Pseudomonas aeruginosa in a hematology unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Multi-resistant Pseudomonas aeruginosa outbreak associated with contaminated tap water in a neurosurgery intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: analysis of trends in prevalence and epidemiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Nosocomial infections caused by multiresistant Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Extended high-level cross-resistance to antipseudomonal antibiotics amongst Pseudomonas aeruginosa isolates in a university hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Rapidly rising prevalence of nosocomial multidrug-resistant, Gram-negative bacilli: a 9-year surveillance study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Aminoglycoside resistance in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Regulation of polymyxin resistance and adaptation to low-Mg2+ environments

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Two efflux systems expressed simultaneously in multidrug-resistant Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Continuous beta-lactam antibiotic therapy in a double-lung transplanted patient with a multidrug-resistant Pseudomonas aeruginosa infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

In vitro activity of beta-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

In vitro activity of combination therapy with cefepime, piperacillin-tazobactam, or meropenem with ciprofloxacin against multidrug-resistant Pseudomonas aeruginosa strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Multidrug-resistant Pseudomonas aeruginosa cholangitis after endoscopic retrograde cholangiopancreatography: failure of routine endoscope cultures to prevent an outbreak.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

Focused microbiological surveillance and gram-negative beta-lactamase--mediated resistance in an intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1353

10.1592/PHCO.2005.25.10.1353

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference